Average Co-Inventor Count = 10.05
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Merck Shapr & Dohme Corp. (1 from 1 patent)
14 patents:
1. 12428397 - Factor XI activation inhibitors
2. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists
3. 12304899 - Factor XI activation inhibitors
4. 11680060 - Bicycloheptane pyrrolidine orexin receptor agonists
5. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
6. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
7. 9540364 - Benzimidazole tetrahydrofuran derivatives
8. 9527839 - Benzimidazole tetrahydropyran derivatives
9. 9382243 - Azabenzimidazole tetrahydropyran derivatives
10. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
11. 9029377 - Platelet-activating factor receptor antagonists
12. 8853212 - Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
13. 8796258 - Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
14. 7687492 - 1,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes